Dr. Shaily Dinesh Shah, MD

Dr. Shah practices at Northern California Cornea Associates Inc in Oakland, California.

Dr. Shah's NPI, 1518386663, was assigned on April 15, 2014. Dr. Shah graduated from Icahn School Of Medicine At Mount Sinai in 2014. Dr. Shah holds California license A170934.

Dr. Shah's primary practice is Northern California Cornea Associates Inc, at 3300 Webster St, Oakland, CA 94609 in Alameda County. The practice phone is (925) 947-0888.

Dr. Shah's primary practice is Northern California Cornea Associates Inc in Oakland, California. Dr. Shah is also affiliated with Alta Bates Summit Medical Center. The medical group on file is Alameda Health System. Dmand AI also links Dr. Shah to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Shah is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Shah's licenses on file in 2 states: California and New York.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Shah treats.

CMS data shows 1,762 Medicare services from Dr. Shah across 13 procedure codes in 2024, for 773 Medicare patients. Medicare paid $203,661 for them.

CMS counts 773 Medicare patients who saw Dr. Shah in 2024. The largest group is 75 to 84, with 320 patients. 73% of them have high cholesterol, and 68% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shah's median patient age at 75, with 60% women.

In 2024, Dr. Shah wrote 2,334 Medicare Part D claims for 504 patients. 58% of them were for generic drugs. CMS names the drug for 2,196 of them, across 30 drugs with 11 or more claims each, at $217,861 in total drug cost. In 2023, CMS named 2,286 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Shah for performance year 2024, reported as part of a group. Dr. Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 198 procedures of cataract surgery by Dr. Shah, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Shah in 2013. 2013 was the busiest year, with 3. The most frequent topics are Intraocular Pressure, Trabecular Meshwork and Disease Models, Animal. Dr. Shah has published most often in Invest Ophthalmol Vis Sci. Dr. Shah's most frequent co-authors are John Danias, MD, PhD, Sandeep Kumar, MD and Sebastian Gordon Bernardo, MD.

CMS Open Payments shows 209 general payments to Dr. Shah from 27 drug and device companies from 2020 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. GlaxoSmithKline, LLC. paid the most, $69,758.

Dr. Shah graduated from Icahn School Of Medicine At Mount Sinai in 2014.

Dr. Shah is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.